Changing Landscape In Latam Pharma Logistics

Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

I have been a professional in logistics and operations for 16 years now, the last 11 of which have been spent working with pharmaceutical companies and the pharma industry. I was the Latin America logistics manager for the inbound shipments into the region. I was then working as a Distribution and supply chain manager for Mexico, and I'm currently responsible for supply chain logistics and security across the whole Latin American region. I have been collaborating with various forums and serving as a panelist at cold chain distribution and pharmaceutical organizations. We're a part of different collaborations.

I also have an MBA from Boston University, and all of these have helped me develop a career in the pharma industry, specifically in logistics operations and supply chain management, mainly in Latin America, with strong connections to Europe, the US, and Asia as well.

Q2. How has Latam supply chain risk profile changed over the last 3–5 years, and where do you still see the most material residual risks to uninterrupted drug supply?

I think specifically for Latam, the main…